Extracorporeal Membrane Oxygenation Machine Market Regional Analysis:
Asia Pacific Market Insights
The extracorporeal membrane oxygenation machine market in the Asia Pacific region is anticipated to hold the largest revenue share of 36% during the assessed time. Collaborations and partnerships among the extracorporeal membrane oxygenation machine manufacturers and local healthcare institutions in the region are promoting technology transfer in different countries. The World Bank is also collaborating with various countries to upgrade their health services. For instance, in March 2023, the World Bank signed a USD 1 billion program to extend support to India’s health sector. These factors play a pivotal role in lifting the medical sector and advanced equipment, including an extracorporeal membrane oxygenation machine. The market in the region is further witnessing robust growth driven by factors such as the increasing incidence of respiratory diseases, initiatives by the government, and advancements in healthcare infrastructure.
North America Market Insights
The market in the North America region is projected to hold the second-largest share during the projection period 2026-2035. The region encounters a high prevalence of cardiovascular diseases that contribute significantly to the demand for extracorporeal membrane oxygenation machines. Also, conditions such as severe heart failure and post-cardiotomy shock require necessary advanced life support for the patient, and the extracorporeal membrane oxygenation machine emerges as a vital intermediate in managing these critical cases effectively. The region is a hub for technological advancements in healthcare. In the U.S., there is a rising cases of lung transplant leading to increased demand for the machines. The government in the U.S. published data in 2022 stating that there were 2,743 lung transplants performed in the country.
